ICI non-responders were enriched in glioblastoma stem cells marked by SOX2 and PTPRZ1 and in cells marked by the IL-6 effector p-STAT3 in both pre- and post-ICI samples compared to ICI responders (Fig. 3b). This evidence concerns the gene SOX2 and glioblastoma.